Cargando…
Systemic administration of an HIV 1 broadly neutralizing dimeric IgA yields mucosal secretory IgA and virus neutralization
We investigated the mucosal distribution and neutralization potency of rhesus recombinant versions of the HIV-specific, broadly neutralizing antibody b12 (RhB12) following intravenous administration to lactating rhesus monkeys. IgG and dimeric IgA (dIgA) administration resulted in high plasma concen...
Autores principales: | Fouda, Genevieve G., Eudailey, Joshua, Kunz, Erika L., Amos, Joshua D., Liebl, Brooke E., Himes, Jonathan, Boakye-Agyeman, Felix, Beck, Krista, Michaels, Anthony J., Cohen-Wolkowiez, Michael, Haynes, Barton F., Reimann, Keith A., Permar, Sallie R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063654/ https://www.ncbi.nlm.nih.gov/pubmed/27072605 http://dx.doi.org/10.1038/mi.2016.32 |
Ejemplares similares
-
Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG
Publicado: (1985) -
Enhanced SARS-CoV-2 neutralization by dimeric IgA
por: Wang, Zijun, et al.
Publicado: (2021) -
Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro
por: Wang, Zijun, et al.
Publicado: (2020) -
Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgG
por: Sun, Lin, et al.
Publicado: (2021) -
Systemic administration of a broadly-neutralizing IgG antibody to generate HIV-neutralization responses in breast milk
por: Fouda, GG, et al.
Publicado: (2012)